Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study

Biological Psychiatry

Volumn 33, Issue 1, 1993, Pages 45-48

  Nisijima, Koichi ^a   Ishiguro, Takeo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DANTROLENE; DOPAMINE; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; SEROTONIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL;

ADULT; DANTROLENE; DOPAMINE; FEMALE; HOMOVANILLIC ACID; HUMAN; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGE; NEUROLEPTIC MALIGNANT SYNDROME; RETROSPECTIVE STUDIES; SEROTONIN;

EID: 0027398745     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(93)90277-K     Document Type: Article

References (20)

1. Treatment of neuroleptic malignant syndrome with dantrolene sodium: A case report
2. Calcium and calmodulin control of neurotransmitter synthesis and release
3. Determination of homovanillic acid in urine by liquid chromatography with electrochemical detection
4. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: A report of two cases
5. Neuroleptic malignant syndrome: Successful treatment with dantrolene and bromocriptine
6. Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade?
7. Resolution of neuroleptic malignant syndrome with dantrolene sodium: Case report
8. Liquid chromatography with pre-column sample enrichment and electrochemical detection. Regional determination of serotonin 5-hydroxyindoleacetic acid in brain tissue
9. Therapy of Neuroleptic malignant syndrome
10. Neuroleptic malignant syndrome
11. Neuroleptic malignant syndrome: Response to dantrolene sodium
12. Transmitter release induced by injection of calcium ions into nerve terminals
13. Neuroleptic malignant syndrome: A study of CSF monoamine metabolism
14. Effects of dantrolene sodium on GABAergic activity in spinal cord, corpus striatum, substantia nigra and cerebral cortex in rat
15. Neuroleptic malignant syndrome: Review of response to therapy
16. The role of calcium in the release of neurotransmitter substances and hormones
17. Dantrolen in der Behandlung lebensbedrohlicher psychiatrische Krankheitsbilder
18. Psychiatric applications of bromocriptine therapy
19. Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs
20. Dantrolene: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity